BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7769672)

  • 1. The YXXL signalling motifs of the bovine leukemia virus transmembrane protein are required for in vivo infection and maintenance of high viral loads.
    Willems L; Gatot JS; Mammerickx M; Portetelle D; Burny A; Kerkhofs P; Kettmann R
    J Virol; 1995 Jul; 69(7):4137-41. PubMed ID: 7769672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The YXXL sequences of a transmembrane protein of bovine leukemia virus are required for viral entry and incorporation of viral envelope protein into virions.
    Inabe K; Nishizawa M; Tajima S; Ikuta K; Aida Y
    J Virol; 1999 Feb; 73(2):1293-301. PubMed ID: 9882334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on bovine leukemia virus envelope glycoprotein gp30 YXXL sequences in virus infection and fusogenic activity].
    Inabe K
    Hokkaido Igaku Zasshi; 1998 May; 73(3):239-52. PubMed ID: 9719950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three YXXL Sequences of a Bovine Leukemia Virus Transmembrane Protein are Independently Required for Fusion Activity by Controlling Expression on the Cell Membrane.
    Matsuura R; Inabe K; Otsuki H; Kurokawa K; Dohmae N; Aida Y
    Viruses; 2019 Dec; 11(12):. PubMed ID: 31835517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the proline-rich motif of bovine leukemia virus transmembrane protein gp30 in viral load and pathogenicity in sheep.
    Reichert M; Winnicka A; Willems L; Kettmann R; Cantor GH
    J Virol; 2001 Sep; 75(17):8082-9. PubMed ID: 11483753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative mutations in the immunosuppressive region of the bovine leukemia virus transmembrane protein affect fusion but not infectivity in vivo.
    Gatot JS; Callebaut I; Mornon JP; Portetelle D; Burny A; Kerkhofs P; Kettmann R; Willems L
    J Biol Chem; 1998 May; 273(21):12870-80. PubMed ID: 9582317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo infection of sheep by bovine leukemia virus mutants.
    Willems L; Kettmann R; Dequiedt F; Portetelle D; Vonèche V; Cornil I; Kerkhofs P; Burny A; Mammerickx M
    J Virol; 1993 Jul; 67(7):4078-85. PubMed ID: 8389918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo.
    Gatot JS; Callebaut I; Van Lint C; Demonté D; Kerkhofs P; Portetelle D; Burny A; Willems L; Kettmann R
    J Virol; 2002 Aug; 76(16):7956-67. PubMed ID: 12134000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine leukemia virus gp30 transmembrane (TM) protein is not tyrosine phosphorylated: examining potential interactions with host tyrosine-mediated signaling.
    Hamilton VT; Stone DM; Pritchard SM; Cantor GH
    Virus Res; 2002 Dec; 90(1-2):155-69. PubMed ID: 12457971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dileucine and YXXL motifs in the cytoplasmic tail of the bovine leukemia virus transmembrane envelope protein affect protein expression on the cell surface.
    Novakovic S; Sawai ET; Radke K
    J Virol; 2004 Aug; 78(15):8301-11. PubMed ID: 15254202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
    Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L
    J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of the Bovine Leukemia Virus Envelope Glycoproteins Involved in Infectivity, Replication and Pathogenesis.
    de Brogniez A; Mast J; Willems L
    Viruses; 2016 Mar; 8(4):88. PubMed ID: 27023592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The (YXXL/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events.
    Beaufils P; Choquet D; Mamoun RZ; Malissen B
    EMBO J; 1993 Dec; 12(13):5105-12. PubMed ID: 8262054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Even attenuated bovine leukemia virus proviruses can be pathogenic in sheep.
    Florins A; Gillet N; Boxus M; Kerkhofs P; Kettmann R; Willems L
    J Virol; 2007 Sep; 81(18):10195-200. PubMed ID: 17626096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of a Single Envelope N-Linked Glycosylation Site Enhances the Pathogenicity of Bovine Leukemia Virus.
    de Brogniez A; Bouzar AB; Jacques JR; Cosse JP; Gillet N; Callebaut I; Reichert M; Willems L
    J Virol; 2015 Sep; 89(17):8945-56. PubMed ID: 26085161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames.
    Willems L; Kerkhofs P; Dequiedt F; Portetelle D; Mammerickx M; Burny A; Kettmann R
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11532-6. PubMed ID: 7972096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection.
    Portetelle D; Limbach K; Burny A; Mammerickx M; Desmettre P; Riviere M; Zavada J; Paoletti E
    Vaccine; 1991 Mar; 9(3):194-200. PubMed ID: 1645899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance between bovine leukemia virus tax immortalization in vitro and oncogenicity in vivo.
    Twizere JC; Kerkhofs P; Burny A; Portetelle D; Kettmann R; Willems L
    J Virol; 2000 Nov; 74(21):9895-902. PubMed ID: 11024116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo oncogenic potential of bovine leukemia virus G4 protein.
    Kerkhofs P; Heremans H; Burny A; Kettmann R; Willems L
    J Virol; 1998 Mar; 72(3):2554-9. PubMed ID: 9499124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
    Gatei MH; Naif HM; Kumar S; Boyle DB; Daniel RC; Good MF; Lavin MF
    J Virol; 1993 Apr; 67(4):1803-10. PubMed ID: 7680387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.